Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
What is the true clinicopathologic spectrum of neuromyelitis optica?
Clinical Importance of Steps Taken per Day among Persons with Multiple Sclerosis.
N-Cadherin Promotes Recruitment and Migration of Neural Progenitor Cells from the SVZ Neural Stem Cell Niche into Demyelinated Lesions.
Visual pathway abnormalities were found in most multiple sclerosis patients despite history of previous optic neuritis.
Acrolein detection: potential theranostic utility in multiple sclerosis and spinal cord injury.
Cerebrospinal fluid concentrations of ghrelin in patients with multiple sclerosis.
Fingolimod attenuates splenocyte-induced demyelination in cerebellar slice cultures.
APOE Stabilization by Exercise Prevents Aging Neurovascular Dysfunction and Complement Induction.
Autonomic dysfunction in clinically isolated syndrome suggestive of multiple sclerosis.
The expanded spectrum of neuromyelitis optica: evidences for a new definition.
Clinical use of brain volumetry.
Inhibition of Interferon regulatory factor 4 Suppresses Th1 and Th17 Cell Differentiation and Ameliorates Experimental Autoimmune Encephalomyelitis.
Correlation analysis of visual analogue scale and measures of walking ability in multiple sclerosis patients.
Incidence and distribution of extravascular compression of extracranial venous pathway in patients with chronic cerebrospinal venous insufficiency and multiple sclerosis.
T Cell Activation Regulates CD6 Alternative Splicing by Transcription Dynamics and SRSF1.
Association of Cerebrospinal Fluid Levels of Lateral Olfactory Tract Usher Substance (LOTUS) With Disease Activity in Multiple Sclerosis.
CSF cytokines/chemokines as biomarkers in neuroinflammatory CNS disorders: A systematic review.
FDA warns about the risks of unproven surgical therapy for multiple sclerosis.
Human oligodendrocytes in remyelination research.
Testicular hypofunction and multiple sclerosis: Cause or consequence? Author's reply.
Diagnostic Efficacy of Conventional MRI Pulse Sequences in the Detection of Lesions Causing Internuclear Ophthalmoplegia in Multiple Sclerosis Patients.
Disability in multiple sclerosis: When synaptic long-term potentiation fails.
Prognostic factors of acute partial transverse myelitis-reply.
Investigating the Antigen Specificity of Multiple Sclerosis Central Nervous System-Derived Immunoglobulins.
Tackling autoimmunity with gene therapy.
Pages
« first
‹ previous
…
357
358
359
360
361
362
363
364
365
…
next ›
last »